Addressing Barriers to Biosimilar Integration in Cancer Care
A Symposium and Live Webinar conducted at the 2019 Midyear Clinical Meeting and ExhibitionTuesday, December 10, 2019 11:30 a.m. - 1:00 p.m. PT
Register for Live Webinar Download Handout
Handout available at least 24 hours in advance
Pharmacists can expect to see more and more biosimilars developed for oncology. This activity will use cases to present clinical information on the use of biosimilars for supportive and therapeutic cancer care, discuss the barriers to biosimilar adoption, and present strategies to overcome these barriers to realize the full potential of biosimilar medicines.
After providing an overview of the regulatory framework and approval process for biosimilars, those currently on the market for use in oncology will be discussed. The faculty address approved indications, delivery methods, indication extrapolation and curative intent, the role of biosimilars in value-based oncology care, and the importance of provider and patient education strategies to enhance acceptance of biosimilar therapy. Operational barriers and strategies to overcome them will also be presented.
Agenda
11:30 a.m.
Welcome and Introductions
Sandra Cuellar, Pharm.D., BCOP, Activity Chair
11:35 a.m.
Overview of the regulatory framework and approval process for biosimilars
Sandra Cuellar, Pharm.D., BCOP
11:40 a.m.
Clinical review of oncology biosimilars
Sandra Cuellar, Pharm.D., BCOP
12:10 p.m.
Discussion of strategies to overcome barriers to integrating biosimilars into the health system
Jorge J. García, Pharm.D., M.S., M.H.A., M.B.A., FACHE
12:45 p.m.
Faculty Discussion and Questions
Sandra Cuellar, Pharm.D., BCOP, and Jorge J. García, Pharm.D., M.S., M.H.A., M.B.A., FACHE
Learning Objectives
- Summarize the FDA regulatory framework to evaluate biosimilars.
- Describe the application of clinical trial data and the requirements for extrapolation of indications and interchangeability of biosimilars.
- Illustrate biosimilar launch and practice implementation challenges along with best practices to overcome these barriers.
- Describe biosimilars’ role under value-based care and potential economic impact.
Join the Live Broadcast
Join the live interactive webinar using your computer or smart device.
Watch for a confirmation email with additional instructions.
Attend the Live Symposium
Islander Ballroom F, Lower Level
Mandalay Bay North Convention Center
Las Vegas, Nevada
- No registration required
- Arrive early; seating is first-come, first-served
- Feel free to bring your lunch*
*Refreshments are not provided in consideration of the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act.
Target Audience
This activity was planned to meet the educational needs of pharmacists caring for oncology patients.
Format
This activity features slide presentations, active learning, and questions/discussion with faculty.
This activity was planned to meet the educational needs of pharmacists caring for oncology patients.
Format
This activity features slide presentations, active learning, and questions/discussion with faculty.
Process CE by January 31
Claim CE (enter the CE code announced during activity and complete the evaluation).
Verify credit has posted to your NABP eProfile before January 31, 2020.
After ACPE's 60-day deadline, ASHP will no longer be able to report credits.
Download the ASHP LIVE! app to access session materials and links to process CE.
CPE Information
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE #: 0204-000-19-425-L01-P
Activity Type: Application-based
CE Credits: 1.5 hours
Activity Fee: Free of charge
CME Information
Midyear Promo page accreditation for medical copy